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Literature from different parts of the world reported that antibiotic 
abuse is evident in dental practice. One aspect of this abuse is prescri-
bing antibiotics for non-indicated orofacial infections. The use of some 
herbal anti-edematous agents has been recommended for reducing 
post-operative swelling/edema in certain oral and maxillofacial surgical 
procedures. In this review we describe the possible benefits of using 
these agents for certain cases of facial cellulitis in order to reduce the 
number of antibiotic prescriptions for this particular clinical situation. 
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Introduction
Oral infections arise from different microbes that inhabit the oral cavity 
including viral, bacterial, and fungal microorganisms [1]. Bacterial oral 
infections are of major concern because their line of management 
may overlap with antibiotic prescribing and subsequently the possibi-
lity of antibiotic abuse may arise. Although indications for antibiotic 
prescribing in dental infections are well defined [2], recent literature 
still reports a high prevalence of antibiotic abuse in dental practice 
[3, 4]. Facial cellulitis, is an infection in the soft tissues of the face 
that presents as diffuse, erythematous swelling, resulting from the 
spread of pathogenic bacteria which are typically Streptococci and 
Stapholococci. The severity of the infection is initially determined by 
virulence of invading bacteria and the host’s response [5]. Associated 
swelling may worsen with time, with the area characterized by being 
warm, tender, and indurated. It may also be accompanied by fever Received 116-11-2018; Accepted 22-11-2008 
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and lymphadenopathy. Arising from a dental infec-
tion on many occasions, it has been considered a 
classical indication for antibiotics in dental practice 
[6]. The recommendation is to use antibiotics as an 
adjunct to pus drainage as the initial management 
followed by removal of the source of infection at a 
later stage. Timely treatment is essential to prevent 
serious comorbidities associated with facial cellulitis 
[7]. 
A specific clinical scenario relates to chronic pe-
riapical infection associated with maxillary incisors 
that may spread to the upper lip causing a localized 
upper lip swelling, and here the upper lip becomes 
swollen, reddish and tender (Figures 1 & 2). In this 
particular case, a question arises as to whether an 
antibiotic prescription is required to supplement pus 
drainage. Another question arises as to whether al-
ternative medications, that are not associated with 
the anticipated adverse effects of antibiotics, can 
be prescribed. 
This mini review aims at exploring the potential 
use of anti-edematous herbal medications as the 
preferable adjunctive therapy to pus drainage in 
cellulitis affecting the upper lip. 
Methods
A literature search was conducted in MEDLINE/Pub-
Med, Web of Science, and Google Scholar databa-
ses using the following five combinations of MeSH 
Terms: herbal AND dental AND infection; Bromelain 
AND dental; Aescin AND dental; Aescin AND cellu-
litis; Bromelain AND cellulitis. Above search revealed 
no articles. Hence, it was decided to consider arti-
cles with the following two combinations of MeSH 
Terms: Oral surgery AND Aescin; Oral surgery AND 
bromelain.
The search was conducted up to and including 
October 2018. There was no time frame and only 
articles written in English were included. Search 
resulted in 11 articles and after exclusion of non-
English literature and animal studies, 5 articles re-
Figure 1:  Labial cellulitis associated with a periapi-
cal abscess (around tooth apex) related 
to upper central incisor (arrow). Cour-
tesy of Dr Hamsa Sheera and Dr Arwa 
Jafar, Al Madina Saudi Arabia.
Figure 2:  Lip cellulitis associated with odontoge-
nic infection around a maxillary incisor. 
Courtesy of Dr Heba Alshaikh Ali, Am-
man, Jordan.
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sulted; 2 of them were irrelevant after review of 
abstracts and 3 investigated the efficacy of use of 
Bromelain after extraction of third molars to reduce 
postoperative discomfort [8-10]. 
Results and Discussion
Relevant articles reported only the use of Brome-
lain. However, Aescin has been reported to have 
the same advantages and is used either in chronic 
venous insufficiency or in the post-surgical period 
to reduce postoperative edema and swelling, so re-
levant literature on Aescin was included.
Aescin
Our search revealed that there are no studies investi-
gating the effect of Aescin to reduce inflammation, 
swelling or edema in the orofacial region. However, 
it was important to include this herbal medication 
in our report to highlight its potential use in dental 
practice. β-Aescin is a mixture of triterpene saponins 
isolated from horse chestnut seeds (Aesculus hip-
pocastanum, L.) [11]. Vascular efficacy of β-Aescinis 
attributed to improved microcirculation, reduced 
vascular permeability, increased venous tone and 
venous return, resulting in edema reduction [12]. 
This efficacy is attributed to the protective effects 
on endothelial cells from hypoxia and inflammatory 
stimuli [13], and to its modulatory effect on the 
TNF-α-mediated inflammatory pathways [14]. It fur-
ther affects endothelial cell structure and function 
by disrupting the actin cytoskeleton and decreasing 
expression of TNF-α-induced effector proteins indu-
cing disturbances of cholesterol homeostasis [11]. 
Capillary-stabilizing agents similar to Aescin have 
been used efficiently in some medical fields to redu-
ce extravasation of fluid into the tissues thus encou-
raging edema to subside. Aescin has been recom-
mended in the treatment of early stages of chronic 
venous insufficiency [15]. It is effective in reduction 
of skin reddening and cutaneous swelling as a result 
of effects on capillaries and their surrounding con-
nective tissues [16]. Preparations containing Aescin 
have been proven to be safe with the presence of 
sporadic reports on transient gastrointestinal disor-
ders [17]. As clearly indicated by all reported studies, 
it is generally well tolerated. Poisoning with horse 
chestnut seeds is attributed to the toxic esculoside 
component, not to Aescin [18]. The recommended 
daily dose of Aescin is 120 mg divided into three 
daily doses.
Bromelain 
It is interesting to find that Bromelain was the most 
commonly investigated herb in the field of oral sur-
gery, if not the only one. It is one of a group of 
peptide hydrolases, all thiol proteinases, obtained 
from pineapple stems and fruit; orally administered 
in the treatment of inflammation and edema of soft 
tissues associated with traumatic injury. It appears 
to inhibit the production of pro-inflammatory pros-
taglandins, induce production of anti-inflammatory 
Series 1 prostaglandins, and reduce capillary per-
meability [19]. 
Bromelain has gained particular interest in plas-
tic surgery because of its apparent anti-edematous, 
anti-inflammatory, and anticoagulation properties, 
which can be beneficial in postoperative healing, 
and it has been shown to be most effective when 
taken orally [20]. Most recent research on bromelain 
within dental practice was conducted in the past 
5 years and was focused on the potential to redu-
ce postoperative surgical sequelae of swelling and 
edema in dental extraction [8, 21, 22]. However, re-
search on this herbal remedy was conducted initially 
throughout the 1960s and 1970s when a series of 
studies found that the effects of orally administered 
Bromelain included the reduction of edema, brui-
sing, pain, and healing time following trauma and 
surgical procedures [23]. 
A recent systematic review reported that Brome-
lain was found to be effective at controlling posto-
perative pain at 48-72h after surgery, but did not 
achieve a significant effect with regard to edema 
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[24]. An incidence of 1.8% of associated side effects 
is considered very low and it includes diarrhea, nau-
sea, and allergic reaction [25]. When used in the 
perioperative period of surgery, the recommended 
dosing is 500 mg 3 times daily between meals be-
ginning the day of surgery and continuing for 8 
days [26]. 
It is obvious that the literature mentioned above 
have investigated the use of Aescin and Bromelain 
in applications other than dentistry. In dental practi-
ce Bromelain was mentioned for its potential effect 
in reducing postoperative edema after surgical ex-
traction. Yet, a recent systematic review reported 
that Bromelain has no effect in reducing postope-
rative swelling [24]. This will lead to the next ques-
tion; would a medication/herb that could have a 
potential in reducing postoperative edema, be also 
effective as an adjunct in the management of ce-
llulitis? It is important in this report to point out to 
the possible differences in the spread of infection 
between various facial spaces. 
In the upper labial region, the anatomic path of 
infection is attributed to the location of the roots 
of upper central incisors and upper lateral incisors 
which are in 50% of cases close to the labial surface, 
so the swelling would be limited by the attachment 
of the orbicularis oris, and the dense subcutaneous 
tissue at the base of the nose [27]. Infection cau-
sed by anterior teeth often spreads into the levator 
labii superioris and levator anguli oris muscles [28]. 
Appropriate clinical management for this condition 
necessitates drainage of pus depending on its lo-
cation. This can be achieved by either root canal 
treatment, abscess drainage or tooth extraction if 
the tooth is not restorable.
Prescription of antibiotics should not be conside-
red as part of first line treatment in these patients. 
We suggest that antibiotics would not necessarily be 
the first line of management; their use can be avoi-
ded/postponed and a modification can be done in 
this particular clinical scenario. Patients may actually 
benefit from drainage supplemented by a prescrip-
tion of an anti-edematous agent. After achieving 
drainage and prescription of Aescin or Bromelain, 
the patient should be reviewed in 24-48 hours to 
assess response to treatment. If worsening of the 
condition is noticed or if there is no improvement, 
an antibiotic prescription can be considered. 
We suggest the inclusion of Aescin and Brome-
lain in dental formularies so as to introduce it to the 
dental community and encourage dental practitio-
ners to use it in the management of facial cellulitis 
of low-moderate severity, especially when drainage 
is feasible, and patient follow-up is closely perfor-
med. We also recommend that clinical trials on the-
se preparations are conducted to judge their validity 
for use in relevant odontogenic infections. 
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